Skip to main content

UBS Group AG

Position in TERN — Terns Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8

Position in TERN

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,228,726
+276.9% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in TERN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,364,122 across 562 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in TERN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 1,228,726
2025-12-31 325,968
2025-09-30 972,772
2025-06-30 1,171,619
2025-03-31 933,106
2024-12-31 401,658
2024-09-30 69,398
2024-06-30 87,332
2024-03-31 62,769
2023-12-31 108,475
2023-09-30 21,544
2023-06-30 53,075
2023-03-31 5,672
2022-09-30 3,667
2021-12-31 3,775
2021-03-31 2,546